Aspirin for everyone older than 50?: AGAINST
AUTOR(ES)
Baigent, Colin
FONTE
BMJ Publishing Group Ltd.
RESUMO
Current population screening for vascular disease is neither efficient nor effective. Peter Elwood and colleagues believe we should have a public information strategy highlighting the benefits (and risks) of aspirin for older people, but Colin Baigent argues that the evidence of benefit is not yet strong enough
